|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease显示文摘 | Alexandre Vallee Yves Lecarpentier Remy Guillevin Jean-Noel Vallee | 2017 | Acta Biochimica et Biophysica Sinica2017，49，10： | 16 |
| 2 | Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas显示文摘In gliomas, the canonical Wingless/Int(WNT)/b-catenin pathway is increased while peroxisome proliferator-activated receptor gamma(PPAR-c) is downregulated.The two systems act in an opposite manner. This review focuses on the interplay between WNT/b-catenin signaling and PPAR-c and their metabolic implications as potential therapeutic target in gliomas. Activation of the WNT/bcatenin pathway stimulates the transcription of genes involved in proliferation, invasion, nucleotide synthesis,tumor growth, and angiogenesis. Activation of PPAR-c agonists inhibits various signaling pathways such as the JAK/STAT, WNT/b-catenin, and PI3 K/Akt pathways,which reduces tumor growth, cell proliferation, cell invasiveness, and angiogenesis. Nonsteroidal anti-inflammatory drugs, curcumin, antipsychotic drugs, adiponectin,and sulforaphane downregulate the WNT/b-catenin pathway through the upregulation of PPAR-c and thus appear to provide an interesting therapeutic approach for gliomas.Temozolomide(TMZ) is an antiangiogenic agent. The downstream action of this opposite interplay may explain the TMZ-resistance often reported in gliomas. | AlexANDre Vallée Yves Lecarpentier Rémy Guillevin Jean-Noёl Vallée | 2018 | Neuroscience Bulletin2018，34，3： | 7 |
| 3 | 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides显示文摘 | J. C. Jennette R. J. Falk P. A. Bacon N. Basu M. C. Cid F. Ferrario L. F. Flores‐Suarez W. L. Gross L. Guillevin E. C. Hagen G. S. Hoffman D. R. Jayne C. G. M. Kallenberg P. Lamprecht C. A. Langford R. A. Luqmani A. D. Mahr E. L. Matteson P. A. Merkel S. | 2012 | Arthritis & Rheumatism2012，，1： | 2 |
| 4 | Tolerance and efficacy ofrituximab and changes in serum B cell biomarkers in patientswith systemic complications of primary Sjagren's syndrome 显示文摘 | Seror R Sordet C Guillevin L | 2007 | Ann Rheum Dis2007，66，3： | 1 |
| 5 | Vasculitis associated with viral infection- s显示文摘 | Cohen P Guillevin L | 2004 | Presse Med2004，33，192： | 1 |
| 6 | Tumor necrosis factor-alpha blockade and the risk of vasculitis显示文摘 | Guillevin L Mouthon L | 2004 | J Rheumatol2004，31，10： | 1 |
| 7 | EULAR recommendations for the management of large vessel vasculitis显示文摘 | Mukhtyar C Guillevin L Cid MC | 2009 | Ann Rheum Dis2009，68，3： | 1 |
| 8 | Low grade marginal zone B cell lymphoma of the breast associated with localized amyloidosis and corpora amylacea in a woman with long standing primary Sjogren's syndrome显示文摘 | Kambouchner M Godmer P Guillevin L | 2003 | J Clin Pathol2003，56，： | 1 |
| 9 | Hypereosinophilic syndromes显示文摘 | Jean Emmanuel Kahn Olivier Ble'try Loic Guillevin | 2008 | Best Practice & Research Clinical Rheumatology2008，22，5： | 1 |
| 10 | Comparison of cell-ELISA, flow eytometry and Western blotting for the detection of antiendothelial cell antibodies 显示文摘 | Revelen R D'Arbonneau F Guillevin L | 2002 | Clin Exp Rheumatol2002，20，1： | 1 |
| 11 | Small solitary littoral cell angioma associated with splenic marginal zone lymphoma and villous lymphocyte leukaemia in a patient with hepatitis C infection显示文摘 | Chatelain D Bonte H Guillevin L | 2002 | Histopathology2002，41，5： | 1 |
| 12 | Churg-Strauss syndrome 显示文摘 | Pagnoux C Guilpain P Guillevin L | 2007 | Curr Opin Rheumatol2007，19，1： | 1 |
| 13 | Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nation-wide prospective multicenter study显示文摘 | Hachulla E Gressin V Guillevin L | 2005 | ArthritisRheum2005，210，52： | 1 |
| 14 | Diagnostic and prognostic rel- evance of neuromuscular biopsy in primary Sjogren' s syndrome-relat- ed neuropathy显示文摘 | Terrier B Lacroix C Guillevin L | 2007 | Arthritis Rheum2007，57，： | 1 |
| 15 | Prevalence of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg - Strauss syndrome in a French urban multiethnic population in 2000: a capture - recapture estimate显示文摘 | Mahr A Guillevin I Poissonnet M | 2004 | Arthritis Rheum2004，51，1： | 1 |
| 16 | Granulomatosis with polyangiitis (Wegener's): an ahernative name for Wegener's granulomatosis 显示文摘 | Falk RJ Gross WL Guillevin L | 2011 | Arthritis Rheum2011，63，4： | 1 |
| 17 | Vasculitis: mechanisms involved andclinical manifestations 显示文摘 | Guillevin L Dorner T | 2007 | Arthritis Res Ther2007，9，2： | 1 |
| 18 | Prophylactic Use of Alfacalcidol in Corticosteroid-Induced Osteoporosis显示文摘 | J. Y. Reginster D. Kuntz W. Verdickt M. Wouters L. Guillevin C.-J. Menke`s K. Nielsen | 1999 | Osteoporosis International1999，，1： | 1 |
| 19 | Brain lymphoma: useful- ness of the magnetic resonance spectroscopy 显示文摘 | Taillibert S Guillevin R Menuel C | 2008 | J Neurooncol2008，86，： | 1 |
| 20 | The Five- Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort 显示文摘 | Guillevin L Pagnoux C Seror R | 2011 | Medicine ( Baltimore)2011，90，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员